For a long time, the world was playing a dangerous game of "catch-up" with cholera. Because there were not enough vaccines to go around, health organizations could only react to outbreaks after they started, rather than preventing them. But as of February 10, 2026, that era of scarcity is officially over.

International health agencies have confirmed that the annual global supply of Oral Cholera Vaccines (OCV) has doubled—moving from 35 million doses in 2022 to over 70 million in 2025, with full distribution hitting its stride this week. This is a massive "Yeah!" moment for global health. On February 9, 2026, the first of 20 million new doses were deployed to Mozambique, with more on the way to the Democratic Republic of the Congo and Bangladesh.

This is not just a story about numbers. It is a story about a massive shift in how we protect vulnerable communities. For the last three years, doctors were forced to give people only one dose of the vaccine instead of the recommended two, just to make the supply last. Now, for the first time since 2022, we have enough "buffer" in the system to return to the full, two-dose regimen that provides long-term protection.

The success comes from a coordinated effort between manufacturers, the WHO, and Gavi. By investing in new production facilities and streamlining the supply chain, they have built a "Global Shield" that can stop an epidemic before it even begins.

I am Henry P., and I believe this proves what is possible when we stop reacting to crises and start building systems to prevent them. This is how we ensure that a child's health is no longer a matter of luck, but a matter of global priority. We are finally ahead of the curve.

Sources: